Evidence map›Paper›PMID 25561904›Full record

ArticleInternational journal of biological sciences2015

Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.

Jue Xie, Dawei Cui, Yan Liu, Jie Jin, Hongyan Tong, Lei Wang, Guoxiang Ruan, Yun Lu, Huiming Yuan

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. How we treat primary immune thrombocytopenia in adults.Journal of hematology & oncology · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jue Xie1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Dawei Cui2. Department of Clinical Laboratory, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Yan Liu1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Jie Jin3. Department of Hematology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Hongyan Tong3. Department of Hematology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Lei Wang1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Guoxiang Ruan1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Yun Lu1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Huiming Yuan1. Department of Blood Transfusion, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 310003.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdiopathic thrombocytopenic purpura (ITP) is a primary autoimmune disease with a decreased platelet count caused by platelet destruction mediated mainly by platelet antibodies. T follicular helper (TFH) cells have demonstrated important roles in autoimmune diseases. The aim of this study is to explore the might role of TFH cells in the patients of ITP.

methodsTwenty-three ITP patients and 12 healthy controls (HC) were enrolled in this study. The frequency of circulating TFH cells in both the patients and HC was analyzed by flow cytometry. Serum interleukin (IL)-21 and IL-6 levels were measured using ELISA, and platelet antibodies were tested using a solid phase technique. Additionally, IL-21, IL-6, Bcl-6 and c-Maf mRNA expressions in peripheral blood mononuclear cells (PBMCs) were detected using real-time PCR.

resultsThe percentages of circulating CXCR5(+) CD4(+)TFH cells with ICOS(high) or PD-1(high) expression were significantly higher in the ITP patients than in the HC. Moreover, the frequencies of circulating CXCR5(+) CD4(+)TFH cells with inducible costimulator (ICOS)(high) or programmed death-1 (PD-1)(high) expression were notably higher in ITP with platelet-antibody-positive ( ITP (+) ) patients than in ITP with platelet-antibody-negative ( ITP (-) ) patients and HC, as were the serum IL-21 and IL-6 levels (significant). Moreover, a positive correlation was found between the CXCR5(+)CD4(+)TFH cells with ICOS(high) or PD-1(high) expression and the serum IL-21 levels of ITP (+) patients. Additionally, the mRNA expression levels of IL-21, IL-6, Bcl-6 and c-Maf were significantly increased in ITP patients, especially in ITP (+) patients.

conclusionsThis study demonstrated TFH cells and effector molecules might play an important role in the pathogenesis of ITP, which are possible therapeutic targets in ITP patients.

Indexed as

AdultAutoimmune DiseasesEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansInterleukin-21Interleukin-6InterleukinsLeukocytes, MononuclearMaleMiddle AgedPurpura, Thrombocytopenic, IdiopathicReceptors, CXCR5T-Lymphocytes, Helper-InducerInterleukin-21Interleukin-6InterleukinsReceptors, CXCR5autoimmune diseaseidiopathic thrombocytopenic purpuraplatelet antibodyT follicular helper cell

Identifiers

PMID25561904
PMCPMC4279097
OpenAlexW2331283103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.